Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4

NCT01056575 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: OC000459

Sponsor

Oxagen Ltd